Citius Oncology prices $9 million offering; shares down over 5%

5 hours ago 1

Citius Oncology (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (NASDAQ:CTXR), announced on Tuesday that it has entered into a securities purchase agreement with a single institutional investor to purchase 5.14 million shares of common stock in a